Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript
Welcome back, everyone, to the 2023 RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotech equity research analysts here at RBC. And we're pleased to be joined by Pacira BioSciences.
Joining us from the company, of course, is the Chairman and CEO, Dave Stack, as well as the Chief Strategy Officer, Ron Ellis. Gentlemen, thanks for joining us.
Thanks for the opportunity, Greg.
Questions & Answers
Yeah. So why don't we dive right in? Certainly, a lot of interesting dynamics when it comes to the surgical environment with EXPAREL and the commercial drivers. But maybe, Dave, we can just have you take a step back and give us a brief overview of Pacira and just the current franchises in non-opioid pain relief.
Yeah. Thank you, Greg. We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
